IMO any offer from $300m or more should be seriously considered. That would solve the finance problem for our 50% of the SNE development over and above the JV funding and leave sufficient funds for our share of the next (2) wells in The Gambia and GB. It would probably leave us with sufficient funds until revenue commenced from SNE and no more dilution would be great! That should add about 5 cps to the share price which would be most welcome ATM.
I don't think a TO is realistic and in any event probably insufficient time to get that across the line before a result from the Arbitration.
ANZ
- Forums
- ASX - By Stock
- FAR
- 2 weeks from Today...
2 weeks from Today..., page-23
-
- There are more pages in this discussion • 329 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
49.5¢ |
Change
-0.010(1.98%) |
Mkt cap ! $46.20M |
Open | High | Low | Value | Volume |
50.5¢ | 50.5¢ | 49.5¢ | $26.98K | 54.03K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 20223 | 49.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
50.5¢ | 611 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20223 | 0.495 |
1 | 2000 | 0.485 |
2 | 28930 | 0.480 |
2 | 70000 | 0.475 |
2 | 78150 | 0.470 |
Price($) | Vol. | No. |
---|---|---|
0.505 | 611 | 1 |
0.510 | 59999 | 2 |
0.525 | 69690 | 1 |
0.530 | 30000 | 1 |
0.535 | 30000 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
FAR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online